Primary malignant lymphoma of the central nervous system. Results of treatment of 11 cases and review of the literature

Journal of Neurosurgery
K MurrayJ Cox

Abstract

Eleven patients with primary malignant lymphoma of the central nervous system (CNS) were treated at the Medical College of Wisconsin Affiliated Hospitals between 1964 and 1984. Three patients had a prior history of immunosuppressive therapy following renal transplantation. All patients had biopsy-proven disease and 10 of the 11 were treated with external radiation therapy. The doses to the primary tumor ranged from 34 to 59.4 Gray (Gy). Actuarial (life-table) survival rate was 82% at 1 year and 43% at 3 years. No recurrence was seen after 13 months. Eighty-six reports totaling 693 cases of primary malignant lymphoma of the CNS were found in the literature. Of these, 308 cases were treated with a combination of surgery and irradiation. Overall survival at 5 years for those patients who received more than 50 Gy compared with less than 50 Gy to the primary tumor was 42.3% versus 12.8% (p less than 0.05). Twenty-one patients survived longer than 5 years. Late relapse was notable, with 10 (47.6%) of 21 tumors recurring between 5 and 12.5 years after diagnosis. Based on this review, a minimum of 50 Gy radiation to the primary tumor is recommended. While no statement regarding the efficacy of craniospinal irradiation or chemotherapy c...Continue Reading

References

Jan 1, 1978·Archives of Neurology·M GarofaloJ G Chusid
Dec 1, 1978·Journal of Neurosurgery·C VaradachariJ L Chason
Apr 1, 1979·Archives of Neurology·R S WilliamsA M Bremer
Sep 1, 1979·Archives of Neurology·R L RuffD G Rawlinson
Apr 1, 1978·Journal of Computer Assisted Tomography·E KaznerO Stochdorph
Apr 1, 1978·Journal of Computer Assisted Tomography·J Radvany, H Levine
Nov 1, 1976·The American Journal of Medicine·A J MatasJ S Najarian
Dec 1, 1975·Clinical Neurology and Neurosurgery·S Stefanko, D Moffe
Jan 1, 1975·Hormone Research·K W Malinowska, K Fotherby
Dec 1, 1975·Forensic Science·A CoutselinisP Varsami
Apr 1, 1985·Journal of Neurosurgery·Y KawakamiA Nishimoto
Jan 1, 1985·Archives of Otolaryngology·A Ierokomos, D W Goin
Jan 1, 1985·Surgical Neurology·G FrankR Ricci
Apr 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J S LoefflerJ R Cassady
May 15, 1971·Lancet·S A Schneck, I Penn
Jul 14, 1973·Lancet·R Hoover, J F Fraumeni
Oct 1, 1973·Journal of Neurology, Neurosurgery, and Psychiatry·M C Gregory, J T Hughes
Jan 1, 1972·Radiology·R W ThompsonJ J Kottra
Aug 1, 1974·Journal of Neurosurgery·E S ChoR S Porro
Oct 1, 1974·Cancer·J M HenryR L Davis
Aug 1, 1974·Journal of Neurology, Neurosurgery, and Psychiatry·L B Barnett, E Schwartz
Oct 1, 1969·Journal of Neurology, Neurosurgery, and Psychiatry·D FisherH Urich
Mar 1, 1967·Annals of Internal Medicine·D G Miller
Jan 1, 1972·Cancer·C FreemanS J Cutler
Jan 1, 1966·Acta Neurologica Scandinavica·S M SamuelssonJ Thorell
Mar 1, 1967·Radiology·R H SagermanC H Chang
Sep 18, 1982·Lancet·J L ZieglerK Yamamoto
Sep 29, 1983·The New England Journal of Medicine·F H HochbergW Henle
Nov 1, 1983·Radiology·R H SagermanG A King
Dec 1, 1983·Radiology·K L WeingartenN E Leeds
Apr 1, 1984·Seminars in Roentgenology·M A Whelan, I I Kricheff
Jan 1, 1984·Neuroradiology·S HoltåsS Cronqvist

❮ Previous
Next ❯

Citations

Mar 1, 1996·Journal of Neuro-oncology·K KleopaH Reichmann
Apr 1, 1996·Journal of Neuro-oncology·S DentD J Stewart
Jan 1, 1995·Neurosurgical Review·K SharmaS Hukku
Jan 1, 1994·Journal of Neuro-oncology·W S Velasquez
Jan 1, 1995·Journal of Neuro-oncology·M T BrownJ P Gockerman
Jan 1, 1995·Journal of Neuro-oncology·A C McDonaldR Rampling
Jan 1, 1992·Journal of Cancer Research and Clinical Oncology·K A Jellinger, W Paulus
Jan 1, 1990·Virchows Archiv. A, Pathological Anatomy and Histopathology·W FeidenU Steude
Feb 1, 1997·Italian Journal of Neurological Sciences·A Boiardi, A Silvani
Oct 1, 1990·Journal of Neuro-oncology·D E WeissmanA B Merkow
Jun 27, 1998·Medical Oncology·W SonsteinJ F Llena
Apr 1, 1989·European Journal of Cancer & Clinical Oncology·R H LiangJ S Shum
Oct 15, 1995·International Journal of Radiation Oncology, Biology, Physics·B P O'NeillR L Krigel
Oct 15, 1995·International Journal of Radiation Oncology, Biology, Physics·M Brada
Nov 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A J FerreriE Villa
Aug 13, 2013·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Keiji TsutsumiKazuhiro Hongo
Jun 30, 2009·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Alain P AlgaziJames L Rubenstein
Mar 29, 2002·Survey of Ophthalmology·Russell W ReadNarsing A Rao
Nov 15, 2002·Survey of Ophthalmology·Dennis M Robertson
Apr 15, 2003·Clinical Neurology and Neurosurgery·Jan GliemrothUlrich Missler
Apr 13, 2000·International Journal of Radiation Oncology, Biology, Physics·N HayabuchiY Onizuka
Aug 1, 1988·International Journal of Radiation Oncology, Biology, Physics·E C HalperinD E Bullard
Jul 2, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·U Basso, A A Brandes
May 7, 1999·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·L LegrosJ L Lagrange
Mar 22, 2002·The Lancet Oncology·S R Plotkin, T T Batchelor
Mar 9, 2002·Retina·Gisela VelezKarl G Csaky
Aug 1, 1992·Acta Neurologica Scandinavica·M WellerH Wiethölter
Apr 1, 1992·Brain Pathology·J W Grant, P G Isaacson
Dec 1, 2006·Neurosurgical Focus·James B Elder, Thomas C Chen
Dec 1, 2006·Neurosurgical Focus·Oussama Abla, Sheila Weitzman
Apr 1, 1995·Journal of Neurosurgery·F H TomlinsonB P O'Neill
Feb 5, 2000·Journal of Neurosurgery·B BatailleF Lapierre

❮ Previous
Next ❯

Methods Mentioned

BETA
bone
biopsy
surgical resection

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.